The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.083%)
Open: 485.00
High: 485.00
Low: 485.00
Prev. Close: 485.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Review of strategic options

31 Aug 2022 07:00

RNS Number : 6663X
System1 Group PLC
31 August 2022
 

31 August 2022

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Review of strategic options for increasing shareholder value

 

Following a review of the Company's recent performance, the board of the Company (the "Board") has decided to conduct a review of its strategic options for growing the business and increasing shareholder value (the "Review").

 

In recent years the Company has invested significantly in developing and launching the "Test Your…" marketing technology platform which provides automated predictions on the effectiveness of advertisements (Test Your Ad), innovations (Test Your Idea) and brand strength (Test Your Brand). In addition, System1 has reshaped much of the business, automated many of its products, raised its industry profile and developed a management team capable of achieving its goal of becoming the world's marketing decision-making platform.

 

The current strategy has led to significant growth in Test Your Ad revenues for the Group, and the launch of additional products such as Test Your Brand and Test Your Idea. System1 has also developed partnerships with companies including ITV, LinkedIn, Globo and a number of creative agencies to increase the number of customers that benefit from its automated prediction products. At the same time, the Group's revenue from its historic bespoke consulting services has been impacted as customers convert to the faster, cheaper standard products.

 

The Company estimates that its target markets of predicting and improving advertising, brand and innovation effectiveness represent about $10bn of the ca $90bn spent annually on market research according to ESOMAR (esomar.org). Currently with the Company having less than a 1% share of its target market, the Board believes that System1 is very well placed to enjoy significant growth in the next decade.

 

Whilst the Company can continue with its current strategy, the Board believes that it is important to ensure that it has explored all strategic options to capitalise on System1's current market opportunity to deliver shareholder value, including considering the value it can create in its current form, the options for increasing organic growth through forming partnerships, and external or internal investment to grow revenue by leveraging the significant investment made in automated predictions technology. The initial conclusions of the Review are expected to be ready by the end of November. The Board has decided to postpone the currently planned tender offer and the current share buyback programme, with decisions on future returns of capital being considered as part of the overall Review. 

 

The Review will be led by the Company's independent Non-executive Directors, supported by the Company's retained advisor, Canaccord Genuity, with another adviser/s if required. 

 

The Board has also today separately announced the appointment of Conrad Bona as a non-executive director of the Company.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement, this inside information is now considered to be in the public domain and the Company confirms that it currently has no inside information.

 The Company can be found at www.system1group.com.

 For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Founder and Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIATIIIVIF
Date   Source Headline
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.